Key Highlights

  • ZSTK shares fell roughly 15.7% in Thursday pre-market trading to $4.18, pulling back from a prior close near $4.96 after Wednesday's session saw the stock spike as much as 243% intraday to a close of $4.90, a 166.29% gain on the day.
  • The rally and Reversal both trace to Wednesday's announcement that Puple AI and Blockcat will contribute roughly $1 billion in Memecore ($M) tokens to ZeroStack, with the company receiving about 925.9 million tokens valued at $1.08 each.
  • The same disclosure flagged significant Shareholder dilution risk, with up to 39.7 million new shares issuable through warrants priced at $25.19 per share (over 12 times ZeroStack's recent trading price), subject to shareholder approval under Nasdaq Rule 5635.
  • ZeroStack, formerly Flora Growth Corp. before its January 2026 rebrand, also operates a pharmaceutical distribution Business in Germany through Subsidiary Phatebo GmbH alongside its newer digital-asset treasury strategy.

Parabolic Move Gives Back Ground In Pre-Market Trading

ZeroStack (NASDAQ:ZSTK) stock is retreating sharply in Thursday's pre-market session after one of the more extreme single-day moves in the small-cap Nasdaq universe this month. On Wednesday, August 19, ZSTK jumped as much as 243% intraday and closed up 166.29% at $4.90 after the company disclosed a definitive agreement under which Puple AI and Blockcat will contribute approximately $1 billion worth of Memecore tokens, with ZeroStack receiving roughly 925.9 million $M tokens valued at $1.08 each. With no incremental positive catalyst overnight, shares are giving back a meaningful portion of that spike, down about 15.7% pre-market to $4.18.

Dilution Disclosure Weighs On Sentiment

The same 8-K that detailed the token contribution also disclosed the transaction's dilutive mechanics: 3.5 million common shares plus warrants priced at $25.19 per share, which management itself acknowledged 'creates dilution,' with total potential issuance of up to roughly 39.7 million new shares. Those Warrant shares require shareholder approval under Nasdaq Listing Rule 5635 and carry a lock-up of up to ten years. As investors had more time to digest a deal that, while large in headline dollar terms, could substantially expand the share count, some of Wednesday's enthusiasm appears to be cooling into Thursday's session.

A Company Still In Transition

ZeroStack was known as Flora Growth Corp., a cannabis-focused company, until it rebranded in January 2026 as it repositioned toward being 'a decentralized AI treasury company that invests in the future of AI infrastructure.' It continues to operate a legacy pharmaceutical distribution business in Germany through subsidiary Phatebo GmbH, which distributes drugs for conditions including cancer, ADHD and multiple sclerosis. Investors are effectively pricing a hybrid company still generating Revenue from pharma distribution while pivoting into a highly speculative crypto-treasury strategy, a combination that has produced outsized Volatility in both directions over the past two trading sessions.

What Investors Should Watch

ZeroStack shares are pulling back in Thursday's pre-market trading as the market digests both sides of Wednesday's $1 billion Memecore token deal: the headline size of the contribution and the accompanying warrant-driven dilution of up to roughly 39.7 million shares. These are the verified facts as reported. Whether shares stabilize may depend on the outcome of the shareholder vote required under Nasdaq Rule 5635 and on how the market ultimately values ZeroStack's now-dual identity as both a pharmaceutical distributor and a digital-asset treasury vehicle.